Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma.

Carbone M, Minaai M, Takinishi Y, Pagano I, Yang H. Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma. J Transl Med. 2023 10 25; 21(1):749.

View in: PubMed

subject areas

Asbestos
HMGB1 Protein
Humans
Lung Neoplasms
Mesothelioma
Tumor Suppressor Proteins
Ubiquitin Thiolesterase

authors with profiles

Ian Pagano. PhD
Michele Carbone, MD, PhD.

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support